Hybrid Cardiovascular Clinical Development Director

GlaxoSmithKline in the UK seeks an accomplished clinical development leader to guide translational and asset-level programs within RIIRU, shaping CDPs and biomarker capabilities while prioritising patient safety and timely study delivery.

You will work cross-functionally with Biology, Regulatory, Medical Affairs and Statistics to design protocols, oversee clinical development timelines, and ensure scientific integrity across early to late-phase studies, with hybrid on-site work at